Incyte Corporation
INCY
$98.07
-$1.97-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.31% | 12.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.31% | 12.38% | |||
| Cost of Revenue | 20.97% | 5.56% | |||
| Gross Profit | 1.83% | 18.47% | |||
| SG&A Expenses | 18.48% | -0.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.09% | 3.31% | |||
| Operating Income | -10.83% | 38.68% | |||
| Income Before Tax | -19.15% | -13.57% | |||
| Income Tax Expenses | 55.94% | -62.00% | |||
| Earnings from Continuing Operations | -29.44% | 4.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.44% | 4.73% | |||
| EBIT | -10.83% | 38.68% | |||
| EBITDA | -10.27% | 36.36% | |||
| EPS Basic | -30.08% | 3.84% | |||
| Normalized Basic EPS | -9.88% | 33.53% | |||
| EPS Diluted | -30.70% | 3.43% | |||
| Normalized Diluted EPS | -10.54% | 32.90% | |||
| Average Basic Shares Outstanding | 0.91% | 0.86% | |||
| Average Diluted Shares Outstanding | 1.66% | 1.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||